Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: increased interleukin-4 production and associated eosinophilia.
What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature.
PLEGRIDY™ (peginterferon beta-1a) approved in the European Union for the treatment of multiple sclerosis
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis.
Rush University Medical Center Sells AMPYRA® Royalty Rights to DRI Capital Managed Fund for Approximately $42 Million
Physical Activity Behavior Change in Persons With Neurologic Disorders: Overview and Examples From Parkinson Disease and Multiple Sclerosis.
In vitro modeling of central nervous system myelination and remyelination.
Is it time for a new global classification of multiple sclerosis?
Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
Evaluating the potential benefit of interferon treatment in multiple sclerosis.
Recurrence of disease activity after repeated Natalizumab withdrawals.
Multiple sclerosis: a primary care perspective.
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination.
The selective anti-IL17A monoclonal antibody secukinumab (AIN457) attenuates IL17A-induced levels of IL6 in human astrocytes.
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.

Pages